Klotho Neurosciences Net Income
| KLTO Stock | 0.28 0.01 3.45% |
As of the 30th of January, Klotho Neurosciences secures the Mean Deviation of 4.48, standard deviation of 5.85, and Risk Adjusted Performance of (0.10). Klotho Neurosciences technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.
Klotho Neurosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Klotho Neurosciences' valuation are provided below:We have found one hundred six available fundamental ratios for Klotho Neurosciences, which can be analyzed and compared to other ratios and to its peers in the industry. Self-guided Investors are advised to check Klotho Neurosciences' last-minute fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 30th of January 2026, Enterprise Value is likely to drop to about 10.4 M This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -5.5 M | -5.3 M | |
| Net Loss | -5.5 M | -5.3 M | |
| Net Loss | (0.37) | (0.35) |
Klotho | Net Income | Build AI portfolio with Klotho Stock |
Evaluating Klotho Neurosciences's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Klotho Neurosciences's fundamental strength.
Latest Klotho Neurosciences' Net Income Growth Pattern
Below is the plot of the Net Income of Klotho Neurosciences over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Klotho Neurosciences financial statement analysis. It represents the amount of money remaining after all of Klotho Neurosciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Klotho Neurosciences' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Klotho Neurosciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (6.15 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Klotho Net Income Regression Statistics
| Arithmetic Mean | (1,139,376) | |
| Coefficient Of Variation | (191.46) | |
| Mean Deviation | 1,591,311 | |
| Median | (913.00) | |
| Standard Deviation | 2,181,446 | |
| Sample Variance | 4.8T | |
| Range | 6.1M | |
| R-Value | (0.72) | |
| Mean Square Error | 2.4T | |
| R-Squared | 0.52 | |
| Significance | 0 | |
| Slope | (311,144) | |
| Total Sum of Squares | 76.1T |
Klotho Net Income History
Other Fundumenentals of Klotho Neurosciences
Klotho Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Klotho Neurosciences is extremely important. It helps to project a fair market value of Klotho Stock properly, considering its historical fundamentals such as Net Income. Since Klotho Neurosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Klotho Neurosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Klotho Neurosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Will Biotechnology sector continue expanding? Could Klotho diversify its offerings? Factors like these will boost the valuation of Klotho Neurosciences. Expected growth trajectory for Klotho significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Klotho Neurosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Klotho Neurosciences is measured differently than its book value, which is the value of Klotho that is recorded on the company's balance sheet. Investors also form their own opinion of Klotho Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Klotho Neurosciences' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Klotho Neurosciences' market value can be influenced by many factors that don't directly affect Klotho Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Klotho Neurosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Klotho Neurosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Klotho Neurosciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Klotho Neurosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Klotho Neurosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Klotho Neurosciences.
| 11/01/2025 |
| 01/30/2026 |
If you would invest 0.00 in Klotho Neurosciences on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding Klotho Neurosciences or generate 0.0% return on investment in Klotho Neurosciences over 90 days. Klotho Neurosciences is related to or competes with Cadrenal Therapeutics, Rallybio Corp, Exicure, Minerva Neurosciences, IBio Common, Neurosense Therapeutics, and TAO Synergies. Klotho Neurosciences is entity of United States More
Klotho Neurosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Klotho Neurosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Klotho Neurosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 28.13 | |||
| Value At Risk | (8.57) | |||
| Potential Upside | 10.34 |
Klotho Neurosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Klotho Neurosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Klotho Neurosciences' standard deviation. In reality, there are many statistical measures that can use Klotho Neurosciences historical prices to predict the future Klotho Neurosciences' volatility.| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (1.06) | |||
| Total Risk Alpha | (1.30) | |||
| Treynor Ratio | (0.27) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Klotho Neurosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Klotho Neurosciences January 30, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.10) | |||
| Market Risk Adjusted Performance | (0.26) | |||
| Mean Deviation | 4.48 | |||
| Coefficient Of Variation | (665.85) | |||
| Standard Deviation | 5.85 | |||
| Variance | 34.26 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (1.06) | |||
| Total Risk Alpha | (1.30) | |||
| Treynor Ratio | (0.27) | |||
| Maximum Drawdown | 28.13 | |||
| Value At Risk | (8.57) | |||
| Potential Upside | 10.34 | |||
| Skewness | 0.8206 | |||
| Kurtosis | 0.9032 |
Klotho Neurosciences Backtested Returns
Klotho Neurosciences has Sharpe Ratio of -0.13, which conveys that the firm had a -0.13 % return per unit of risk over the last 3 months. Klotho Neurosciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Klotho Neurosciences' Standard Deviation of 5.85, risk adjusted performance of (0.10), and Mean Deviation of 4.48 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 3.26, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Klotho Neurosciences will likely underperform. At this point, Klotho Neurosciences has a negative expected return of -0.82%. Please make sure to verify Klotho Neurosciences' total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Klotho Neurosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.62 |
Good predictability
Klotho Neurosciences has good predictability. Overlapping area represents the amount of predictability between Klotho Neurosciences time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Klotho Neurosciences price movement. The serial correlation of 0.62 indicates that roughly 62.0% of current Klotho Neurosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.62 | |
| Spearman Rank Test | 0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Klotho Neurosciences reported net income of (6.15 Million). This is much lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is notably higher than that of the company.
Klotho Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Klotho Neurosciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Klotho Neurosciences could also be used in its relative valuation, which is a method of valuing Klotho Neurosciences by comparing valuation metrics of similar companies.Klotho Neurosciences is currently under evaluation in net income category among its peers.
Klotho Fundamentals
| Return On Equity | -1.98 | ||||
| Return On Asset | -0.72 | ||||
| Current Valuation | 22.24 M | ||||
| Shares Outstanding | 72.54 M | ||||
| Shares Owned By Insiders | 10.53 % | ||||
| Shares Owned By Institutions | 2.56 % | ||||
| Number Of Shares Shorted | 391.81 K | ||||
| Price To Book | 2.12 X | ||||
| EBITDA | (5.79 M) | ||||
| Net Income | (6.15 M) | ||||
| Total Debt | 271.75 K | ||||
| Book Value Per Share | 0.14 X | ||||
| Cash Flow From Operations | (2.95 M) | ||||
| Short Ratio | 0.52 X | ||||
| Earnings Per Share | (0.30) X | ||||
| Beta | 2.48 | ||||
| Market Capitalization | 21.25 M | ||||
| Total Asset | 2.46 M | ||||
| Retained Earnings | (10.56 M) | ||||
| Working Capital | (1.09 M) | ||||
| Net Asset | 2.46 M |
About Klotho Neurosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Klotho Neurosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Klotho Neurosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Klotho Neurosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Klotho Neurosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Klotho Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Klotho Neurosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Klotho Stock
Moving against Klotho Stock
| 0.94 | LION | Lionsgate Studios Holding | PairCorr |
| 0.85 | JRVR | James River Group | PairCorr |
| 0.75 | UPB | Upstream Bio | PairCorr |
| 0.74 | KNYJF | KONE Oyj Earnings Call This Week | PairCorr |
| 0.72 | SUNFF | Sun Life Financial | PairCorr |
The ability to find closely correlated positions to Klotho Neurosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Klotho Neurosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Klotho Neurosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Klotho Neurosciences to buy it.
The correlation of Klotho Neurosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Klotho Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Klotho Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Klotho Neurosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out To learn how to invest in Klotho Stock, please use our How to Invest in Klotho Neurosciences guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Will Biotechnology sector continue expanding? Could Klotho diversify its offerings? Factors like these will boost the valuation of Klotho Neurosciences. Expected growth trajectory for Klotho significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Klotho Neurosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Klotho Neurosciences is measured differently than its book value, which is the value of Klotho that is recorded on the company's balance sheet. Investors also form their own opinion of Klotho Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Klotho Neurosciences' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Klotho Neurosciences' market value can be influenced by many factors that don't directly affect Klotho Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Klotho Neurosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Klotho Neurosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Klotho Neurosciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.